Condition
Local Advanced Rectal Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Local Advanced Rectal Cancer clinical trials that are recruiting, at sites in 2 countries (most in Russia (1), China (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Short-Course Radiotherapy Followed by CAPOX With or Without Iparomlimab and Tuvonralimab in Localized Rectal Cancer
In people with locally advanced, treatment-naive rectal cancer, this study tests whether adding two immunotherapy drugs to a standard chemotherapy after short-course radiotherapy can improve tumor response.
-
Low anterior resection with or without a preventive diverting stoma for low-risk rectal cancer patients
This trial tests whether adults having minimally invasive total mesorectal excision for mid- or low-rectal cancer with a low predicted leak risk can safely avoid a temporary diverting stoma.
Related topics
Quick answers
How many Local Advanced Rectal Cancer clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Russia (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.